Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Amortizatization of Intangibles (2018 - 2026)

Kiniksa Pharmaceuticals International filings provide 6 years of Amortizatization of Intangibles readings, the most recent being -$1.3 million for Q1 2026.

  • On a quarterly basis, Amortizatization of Intangibles fell 410.59% to -$1.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$131000.0, a 67.17% increase, with the full-year FY2025 number at $916000.0, up 307.71% from a year prior.
  • Amortizatization of Intangibles hit -$1.3 million in Q1 2026 for Kiniksa Pharmaceuticals International, down from $930000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $1.2 million in Q2 2023 to a low of -$1.4 million in Q3 2023.
  • Median Amortizatization of Intangibles over the past 5 years was $119000.0 (2022), compared with a mean of $19000.0.
  • The widest YoY moves for Amortizatization of Intangibles: up 1615.79% in 2023, down 1310.92% in 2023.
  • Kiniksa Pharmaceuticals International's Amortizatization of Intangibles stood at $203000.0 in 2022, then skyrocketed by 45.81% to $296000.0 in 2023, then tumbled by 376.69% to -$819000.0 in 2024, then soared by 213.55% to $930000.0 in 2025, then plummeted by 240.0% to -$1.3 million in 2026.
  • The last three reported values for Amortizatization of Intangibles were -$1.3 million (Q1 2026), $930000.0 (Q4 2025), and -$603000.0 (Q3 2025) per Business Quant data.